Ascites due to cirrhosis of the liver, mechanical obstruction or cardiac failure.
肝硬化腹水的肝，机械阻塞或心脏衰竭。
Methods 19 patients with liver cirrhosis were retrospectively analyzed clinical data on the treatment of ascites due to cirrhosis forward-looking inquiry.
方法通过19例肝硬化腹水患者临床资料进行回顾性分析，对肝硬化腹水的治疗方法前瞻性探究。
Aim to investigate the clinical factors influencing the therapeutic response to diuretic treatment of ascites in liver cirrhosis.
目的探讨利尿剂治疗肝硬化腹水疗效的部分影响因素。
Objective To study the therapeutic effects of self-drafted Guzhang prescription in treatment of patients of liver cirrhosis (LC) and ascites.
目的探讨自拟鼓胀方对肝硬化(LC)腹水的治疗作用。
Methods Data of cases of liver cirrhosis with ascites hospitalized in our institute were collected in 680 and studied one by one.
方法收集我院肝硬变腹水住院病人病历680份，逐份分析。
To study the changes of cytokines in serum and ascites in liver cirrhosis patients with ascites and spontaneous peritonitis so as to instruct clinical use of antibiotics.
目的探讨肝硬化腹水及并发自发性细菌性腹膜炎时，血清及腹水中细胞因子水平的变化特点，从而指导临床使用抗生素。
Objective: To explore the clinical effect of the liver cirrhosis self - ascites concentrated and reinfusion by using F6 dialyzer.
目的：探讨应用F6型透析器进行肝硬化自体腹水浓缩透析回输的临床效果。
Such four cases as ascites due to cirrhosis, portal hypertension; non-alcoholic fatty liver and jaundice were presented for a detailed explanation.
今举肝硬化腹水、门静脉高压症、非酒精性脂肪肝、黄疸四则验案详细说明之。
Conculsion Childs-Pugh score and plasma creatinine level were the risk factors influencing the therapeutic response to diuretic treatment of ascites in liver cirrhosis.
结论肝功能分级和血肌酐水平是影响肝硬化腹水利尿剂疗效的重要因素。
Conclusion: it is effective on the liver cirrhosis self-ascites concentrated and reinfusion by using F6 dialyzer.
结论：应用F6型透析器进行肝硬化自体腹水浓缩透析回输治疗肝硬化腹水效果良好。
Objective: to investigate and sort out the experience of an aged TCM. doctor of Hanzhexian in treating ascites due to liver cirrhosis.
前言：目的：探讨并整理名老中医韩哲仙治疗肝硬化腹水的经验。
New medicines such as vasoconstrictors and V2-receptors of vasopressin maybe beneficial in patients with ascites in liver cirrhosis.
新药(如V 2受拮抗剂和血管收缩剂等)对肝硬化腹水的治疗可能带来希望。
New medicines such as vasoconstrictors and V2-receptors of vasopressin maybe beneficial in patients with ascites in liver cirrhosis.
新药(如V 2受拮抗剂和血管收缩剂等)对肝硬化腹水的治疗可能带来希望。
应用推荐